|
?:authorAffiliation
|
-
[\'NHS England and NHS Improvement, London, UK; NHS Digital, Leeds, UK; Institute of Cardiovascular & Medical Sciences, University of Glasgow, Glasgow, UK.\', \'NHS Digital, Leeds, UK.\', \'NHS England and NHS Improvement, London, UK; Portsmouth Hospitals NHS Trust, Portsmouth, UK.\', \'NHS England and NHS Improvement, London, UK.\', \'Public Health England, York, UK.\', \'Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, UK.\', \'MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.\', \'Institute of Cardiovascular & Medical Sciences, University of Glasgow, Glasgow, UK.\', \'Diabetes UK, London, UK.\', \'NHS England and NHS Improvement, London, UK; Department of Diabetes and Endocrinology, St Mary\'s Hospital, Imperial College Healthcare NHS Trust, London, UK; Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, UK. Electronic address: jonathan.valabhji@nhs.net.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}